General Block:
Various dosage forms like tablets, capsules, ointment, syrup, cream are manufactured in this block as per the cGMP regulation.  

Cephalosporin Block:
As per the cGMP regulation, National Healthcare manufactures Cephalosporin antibiotic products in self-contained and dedicated Cephalosporin block to prevent cross contamination and unintended possible health concerns to the patients and co-workers with cephalosporin sensitivity. Various tablets, capsules, dry powder for oral suspension/syrup and dry powder for injections are currently being manufactured in this block. With diligent professionals, National Healthcare also manufactures combination products of Cephalosporin with Clavulanate Potassium formulated in different dosage forms.

.

overview

Penicillin Block:
For the manufacturing of Penicillin antibiotics, National Healthcare has another self contained, separate and dedicated block built in accordance with the International Regulatory Guidelines. Key dosage forms of this facility include tablets, capsules, powder for oral suspension / syrup and dry powder for injections. Combination product of Amoxicillin and Clavulanate Potassium of National Healthcare is one of the leading products in the country. A combination of Piperacillin and Tazobactam dry powder for injection is also manufactured.

overview

Sterile Block:
These preparations include anti-inflammatories, anti-infectives, anti-spasdomics, anti-histaminics, anti-cholinergics, analgesics, anaesthetics and vitamin supplements.
Maintaining least human movement, both aseptically filled and terminally sterilized products of four categories are manufactured in this department viz: 

  1. Small volume parenterals
  2. Ophthalmic products
  3. Otic products
  4. Lyophilized products


Lyophilized Line:

For the first time in the country, National Healthcare has introduced Lyophilized line as an extension to its sterile facility. Soon the company will serve the domestic pharma sector with lyophilized medicines and take the country one step closer to self sustainability. Currently Pantoprazole, Rabeprazole, Vancomycin and Vecuronium lyophilized injections are in the development and pre-marketing stage and in the future the company plans to come up with more products.